-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Maintains Buy on Contineum Therapeutics, Raises Price Target to $30

Benzinga·10/15/2026 16:46:37
语音播报
Jones Trading analyst Debanjana Chatterjee maintains Contineum Therapeutics (NASDAQ:CTNM) with a Buy and raises the price target from $24 to $30.